"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
Christina Farr, Luba Greenwood, Ash Zenooz
39 episodes
4 months ago
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us.
We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.
Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.
Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
All content for "Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD is the property of Christina Farr, Luba Greenwood, Ash Zenooz and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us.
We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.
Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.
Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co
Distribution advantage: Are influencers the new moat in healthcare? with Headline VC's Georgina McMillan
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
38 minutes
9 months ago
Distribution advantage: Are influencers the new moat in healthcare? with Headline VC's Georgina McMillan
The week on Second Opinion, Christina Farr and Luba Greenwood sit down with Georgina McMillan to discuss the impact of celebrities and influencers on the healthcare and longevity sectors, exploring how their endorsements and social media presence can both promote health awareness and lead to misinformation, and the need for authentic and scientifically-backed partnerships.
—
📰 Be notified early when Turpentine drops new publication: https://www.turpentine.co/exclusiveaccess
🙏 Help shape our show by taking our quick listener survey at https://bit.ly/TurpentinePulse
—
SPONSOR:
👩⚕️ Hot flashes, insomnia, brain fog? You don't have to accept these as just another part of aging. Midi Health is the virtual care clinic for women navigating midlife hormonal transition, offering FDA-approved medications, supplements and lifestyle coaching - all covered by insurance. Visit https://www.joinmidi.com/ to book your virtual visit today.
—
RECOMMENDED PODCAST:
Check out Modern Relationships, where Erik Torenberg interviews tech power couples and leading thinkers to explore how ambitious people actually make partnerships work. Founders Fund's Delian Asparouhov and researcher Nadia Asparouhova kick off the series with an unfiltered conversation about their relationship evolution.
Apple: https://podcasts.apple.com/us/podcast/id1786227593
Spotify: https://open.spotify.com/show/5hJzs0gDg6lRT6r10mdpVg
YouTube: https://www.youtube.com/@ModernRelationshipsPod
—
LINKS:
Headline: https://headline.com/
Apple Cider Vinegar (Netflix): https://www.netflix.com/title/81637595
Subscribe to Second Opinion Newsletter: https://secondopinion.media/
—
FOLLOW:
https://www.linkedin.com/in/georgie-mcmillan/
https://www.linkedin.com/in/christinafarr/
https://www.linkedin.com/in/lubagreenwood/
https://www.linkedin.com/in/ashzenooz/
—
HIGHLIGHTS FROM THE EPISODE:
There's a distinction between celebrity doctors starting their own businesses and traditional celebrities getting involved in health companies.
Social media has become crucial for healthcare distribution, allowing doctors to grow their practices by building online authority.
Celebrity partnerships may solve rising customer acquisition costs by offering startups access to built-in audiences.
Trust and authenticity are essential for effective celebrity involvement in healthcare.
The longevity trend raises concerns, particularly when physicians promote products without clinical evidence.
Social media rewards extreme content, which can lead to health misinformation.
Vanity and aesthetics can positively motivate health behaviors.
There's a trend shifting from artificial fillers toward natural-looking solutions based on real science.
The beauty industry draws healthcare resources away from traditional care into more lucrative aesthetic practices.
Celebrity motivations range from authentic interest to financial incentives.
Olivia Munn's breast cancer diagnosis post demonstrates the powerful positive impact celebrities can have on public health education.
Celebrity attention to rare diseases can be crucial for driving research and finding cures.
Celebrities and influencers can be powerful patient advocates when connected to scientifically-backed products and services.
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us.
We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.
Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings.
Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co